<DOC>
	<DOC>NCT00151970</DOC>
	<brief_summary>This study will assess the efficacy, duration of effect, tolerability and safety of 4- and 6- hour wear times of SPD485 in 6-12 year old subjects diagnosed with ADHD.</brief_summary>
	<brief_title>Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD</brief_title>
	<detailed_description>Attention-Deficit/Hyperactivity Disorder (ADHD) is a psychiatric disorder characterized by 3 main symptoms: inattention, hyperactivity and impulsivity. This study will assess the efficacy, duration of effect, tolerability and safety of 4- and 6- hour wear times of SPD485 in 6-12 year old subjects diagnosed with ADHD.</detailed_description>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Subjects have primary diagnosis of ADHD Females of childbearing potential must have a negative serum beta Human Chorionic Gonadotropin (HCG) pregnancy test Subject has an IQ score of &gt;_ 80 Subject is able to complete as least the Basic Test of the PERMP assessment Subject has a comorbid psychiatric diagnosis such as Axis II disorders or severe Axis I disorders Subject is taking Strattera(r) Subject has a recent history of suspected substance abuse or dependence disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>